KIZOO Technology Capital

KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech.

Business Model:

Revenue: $14.7M

Employees: 51-200

Rankings

Detailed KIZOO Technology Capital Information

Geographic Data

KIZOO Technology Capital headquarters map

Address: Amalienbadstraße 41

City: Karlsruhe

State: baden-württemberg

Zip: 76227

Country: DE

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

6,062,778Website Global Rank

1,269Website Monthly Traffic

Twitter Followers

Description

KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech. Having been entrepreneurs, VCs and mentors in both, high growth tech and biotech companies theirselves for many years with multiple exits and massive value created for the founders, they now bring this experience to the emerging field of rejuvenation biotech - a young industry that will eventually become much bigger than today&s;s largest technology markets. ​ As part of the Forever Healthy Group, they directly support the creation of startups that turn research on the root causes of aging into therapies and services for humans. ​ Forever Healthy&s;s other initiatives include the evaluation of new rejuvenation therapies, evidenced-based curation of the world&s;s cutting-edge medical knowledge, funding research projects on the root causes of aging and hosting the annual Undoing Aging Conference.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
1/2017 MOQO Seed Round -
7/2015 Prescreen Seed Round -
4/2011 Advertory Seed Round -
1/2015 Oisin Biotechnologies Seed Round -
8/2014 Mambu Series A 2.7M
10/2019 MAIA Biotech Seed Round 1.5M
8/2019 LIfT BioSciences Series A 2.4M
12/2012 Mambu Series A 1.8M
7/2011 Pactas GmbH Seed Round -
1/2016 Mambu Series B 8.7M
3/2021 Staffbase Series D 0
11/2012 Hojoki Series A -
3/2011 MegaZebra Series B -
11/2011 tamyca Series A -
6/2019 Turn.bio Seed Round -
7/2018 FoxBio Venture Round 10M
7/2008 Babbel Seed Round -
10/2017 Elevian Convertible Note 2.6M
6/2018 Staffbase Series B 10M
3/2013 Babbel Series B 10M
8/2017 Antoxerene Seed Round 1.5M
11/2019 Underdog Pharmaceuticals Seed Round 4M
11/2020 Elevian Seed Round 0
8/2014 Suitepad Seed Round -
7/2019 Staffbase Series C 23M
1/2021 Cellvie Seed 5M
8/2017 AgeX Therapeutics Venture Round 0
1/2010 MegaZebra Series A -
1/2011 Mambu Seed Round 821.4k
10/2022 Mogling Bio Seed Round -
4/2022 Elastrin Therapeutics Venture Round 10M
11/2014 shyftplan Pre Seed Round 1.8M
3/2022 Revel Pharmaceuticals Seed 8.4M
9/2021 Underdog Pharmaceuticals Seed 10M
11/2012 Hipaway Seed Round -
11/2015 Staffbase Seed Round -
5/2016 Staffbase Series A 2.3M
10/2020 Staffbase Series C 0
9/2017 shyftplan Seed Round 3.6M
10/2019 MAIA Biotech Seed Round -
10/2018 MOQO Seed Round -
5/2017 CellAge Seed Round -
11/2011 Hojoki Seed Round 620k
2/2016 Suitepad Series A 3.3M
3/2016 Ichor Therapeutics Seed Round 1.4M
3/2021 Elastrin Therapeutics Seed Round 2.5M
1/2017 Lysoclear Seed Round -
4/2022 Elastrin Therapeutics Venture Round 0
3/2022 Revel Pharmaceuticals Seed Round 0
9/2021 Underdog Pharmaceuticals Seed Round 0
3/2021 Staffbase Series D 0
3/2021 Elastrin Therapeutics Seed Round 0
1/2021 Cellvie Seed Round 0
11/2020 Elevian Seed Round 0
10/2020 Staffbase Series C 0
11/2019 Underdog Pharmaceuticals Seed Round 0
10/2019 MAIA Biotech Seed Round -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research